Sorted By:

Relevance


PhRMA Supports Stand Up To Cancer’s Mission of Promoting Cancer Research

PhRMA  |  Press Release

Washington, D.C. (September 9, 2010) – Cancer, the second leading cause of death in the United States, affects more than 10 million Americans. The World Health Organization has suggested that this year, the disease will become the world’s leading cause of death. That’s why...
https://www.phrma.org/press-release/phrma-supports-stand-up-to-cancer-s-mission-of-promoting-cancer-research

PhRMA Statement Marking the Passage of Civil Rights Pioneer

PhRMA  |  Press Release

Washington, D.C. (April 20, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President for Government Affairs/Diversity Programs Larry Lucas issued the following statement today regarding the death of Dorothy Height: “Less than one week after mourn...
https://www.phrma.org/press-release/phrma-statement-marking-the-passage-of-civil-rights-pioneer

PhRMA and EFPIA Applaud Push for EU-US Trade Agreement

PhRMA  |  Press Release

Washington, D.C. and Brussels (February 12, 2013) —The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) welcome today’s announcement of a new trade agreement that will strengthen economi...
https://www.phrma.org/press-release/phrma-and-efpia-applaud-push-for-eu-us-trade-agreement

R&D Investment by U.S. Biopharmaceutical Companies Reached Record Levels in 2010

PhRMA  |  Press Release

Washington, D.C. (March 15, 2011) — Demonstrating a steady and ongoing commitment to innovative R&D, America’s biopharmaceutical research companies invested a record $67.4 billion last year in the research and development of new medicines and vaccines – an increase of $1.5 bi...
https://www.phrma.org/press-release/randd-investment-by-u-s-biopharmaceutical-companies-reached-record-levels-in-2010

PhRMA Statement on House Tri-Committee Health Reform Bill

PhRMA  |  Press Release

Washington, D.C. (July 14, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement about the House Tri-Committee health care reform bill: “PhRMA cannot support the Tri-Committee bill but we belie...
https://www.phrma.org/press-release/phrma-statement-on-house-tri-committee-health-reform-bill

Lori Reilly to Lead PhRMA Policy & Research Department

PhRMA  |  Press Release

WASHINGTON, D.C. (May 21, 2013) –  The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Lori Reilly will become Executive Vice President of Policy and Research, effective June 7, 2013. She succeeds Rick Smith, who will retire after 11 years of ser...
https://www.phrma.org/press-release/lori-reilly-to-lead-phrma-policy-and-research-department

Scientists Honored With Discoverers Award For Development of Innovative HIV Medicine

PhRMA  |  Press Release

Washington, D.C. (March 18, 2010) — Three scientists who led the 11-year quest to develop a groundbreaking HIV drug today received the 2010 Discoverers Award – the highest honor given to scientists by the Pharmaceutical Research and Manufacturers of America (PhRMA). The honorees ...
https://www.phrma.org/press-release/scientists-honored-with-discoverers-award-for-development-of-innovative-hiv-medicine

Pharmaceutical Organizations Announce Key Principles to Foster Supply Chain Security and Integrity

PhRMA  |  Press Release

Washington, D.C. (January 30, 2013) The100th meeting of the National Conference of Pharmaceutical Organizations (NCPO) resolved that the member organizations will work together to help further secure the pharmaceutical supply chain. “Supply chain issues go to th...
https://www.phrma.org/press-release/pharmaceutical-organizations-announce-key-principles-to-foster-supply-chain-security-and-integrity

PhRMA Statement on Harvard Study on Medicare Part D

PhRMA  |  Press Release

Washington, D.C. (October 6, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matt Bennett issued the following statement on new research by Harvard showing reduced hospital visits as a result of Medicare Part D:   “A new st...
https://www.phrma.org/press-release/phrma-statement-on-harvard-study-on-medicare-part-d

Comparative Clinical Effectiveness Research Provision An Important Step Forward for Patient Care

PhRMA  |  Press Release

Washington, D.C. (February 11, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding the economic stimulus package and comparative clinical effectiveness research: “PhRMA suppor...
https://www.phrma.org/press-release/comparative-clinical-effectiveness-research-provision-an-important-step-forward-for-patient-care

Celgene’s Robert J. Hugin Becomes PhRMA Board Chairman

PhRMA  |  Press Release

San Diego, CA (April 12, 2013) — Robert J. Hugin, chairman and CEO of Celgene Corporation, was elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the trade association’s annual meetin...
https://www.phrma.org/press-release/celgene-s-robert-j-hugin-becomes-phrma-board-chairman

Partnership for Prescription Assistance Provides Trusted, Reliable and Free Help to Struggling Americans

PhRMA  |  Press Release

Washington, DC (May 6, 2009) – In this period of economic uncertainty, many uninsured and underinsured Americans are going online to seek help getting the prescription medicines they need. America’s pharmaceutical research and biotechnology companies want patients to know that th...
https://www.phrma.org/press-release/partnership-for-prescription-assistance-provides-trusted-reliable-and-free-help-to-struggling-americans

PhRMA Urges Support for International Standards in Russian Medicines Law

PhRMA  |  Press Release

Washington, D.C. (March 4, 2010) — As Russia embarks on legislative reforms to strengthen pharmaceutical regulation, the Pharmaceutical Research and Manufacturers of America’s (PhRMA) President of International Affairs Christopher A. Singer called on the Russian government to use...
https://www.phrma.org/press-release/phrma-urges-support-for-international-standards-in-russian-medicines-law

Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman

PhRMA  |  Press Release

Biogen CEO George A. Scangos and Johnson & Johnson Worldwide Chairman for Pharmaceuticals Joaquin Duato Assume New Posts ; Castellani Announces Retirement Washington, D.C. (April 16, 2015) — Today, Kenneth C. Frazier, chairman and chief executive offic...
https://www.phrma.org/press-release/merck-chairman-and-ceo-kenneth-c-frazier-becomes-phrma-board-chairman

Share the Savings

PhRMA  |  From PhRMA

According to a recent study from the Berkeley Research Group, more than a third of the list price for brand medicines is rebated back to payers and the supply chain.
https://www.phrma.org/discounts

PhRMA Statement Regarding FDA’s Drug Safety Oversight

PhRMA  |  Press Release

Washington, D.C. (August 2, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding the safety of drug ingredients derived from abroad: “The lifeline of America’s biopharmaceutica...
https://www.phrma.org/press-release/phrma-statement-regarding-fda-s-drug-safety-oversight

PhRMA Statement on Foreign Clinical Trials - 2009

PhRMA  |  Press Release

Washington, D.C. (February 19, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson today issued the following statement on clinical trials conducted abroad: “America’s pharmaceutical research and biotechnology companies ar...
https://www.phrma.org/press-release/phrma-statement-on-foreign-clinical-trials-2009

PhRMA Statement on Health Care Reform Talks - 2009

PhRMA  |  Press Release

Washington, D.C. (June 13, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today regarding health care reform: “We remain committed to working with the Administration and Congress to help en...
https://www.phrma.org/press-release/phrma-statement-on-health-care-reform-talks-2009

PhRMA Statement on Health Care Reform Ad

PhRMA  |  Press Release

Washington, D.C. (January 8, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today regarding PhRMA’s co-sponsorship of an.phrma.org/files/attachments/Factory_Final%20-1_6_08.wmv"...
https://www.phrma.org/press-release/phrma-statement-on-health-care-reform-ad

PhRMA Statement on FDA Biomedical Innovation Report

PhRMA  |  Press Release

Washington, D.C. (October 5, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani issued the following statement:   “We applaud Commissioner Hamburg and the FDA for the thoughtful and proactive approach to support...
https://www.phrma.org/press-release/phrma-statement-on-fda-biomedical-innovation-report

PhRMA Encourages Selection, Confirmation of FDA Commissioner

PhRMA  |  Press Release

Washington, D.C. (January 27, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today on the importance of a Senate-confirmed commissioner for the Food and Drug Administration: “Dr. Frank Tort...
https://www.phrma.org/press-release/phrma-encourages-selection-confirmation-of-fda-commissioner

PhRMA Statement on Patent Reform Agreement

PhRMA  |  Press Release

Washington, D.C. (March 5, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today about a recent patent reform agreement reached by Members of Congress: “We applaud Senators...
https://www.phrma.org/press-release/phrma-statement-on-patent-reform-agreement

PhRMA Statement on Protecting Intellectual Property

PhRMA  |  Press Release

Washington, D.C. (October 26, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement regarding the introduction of the Stop Online Piracy Act:   "PhRMA applauds the introduction of th...
https://www.phrma.org/press-release/phrma-statement-on-protecting-intellectual-property

PhRMA Statement Supporting 21st Century Regulatory System

PhRMA  |  Press Release

Washington, D.C. (Jan. 18, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today regarding federal policies that cultivate medical progress: “PhRMA applauds President Obama’s embrace of o...
https://www.phrma.org/press-release/phrma-statement-supporting-21st-century-regulatory-system

Fostering Access to Innovative Medicines in Indonesia

PhRMA  |  Press Release

Washington, D.C. (December 6, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today in response to the September 3, 2012 Indonesian Presidential Decree (76/2012) that grants compulsory licenses ...
https://www.phrma.org/press-release/fostering-access-to-innovative-medicines-in-indonesia

You have reviewed the first 425 results out of 877. Each page contains 25 results. You're on page 17.

prev 13 14 15 16 17 18 next